Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKD
- 31 July 2007
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 50 (1), 59-68
- https://doi.org/10.1053/j.ajkd.2007.04.010
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Prevalence of Calcidiol Deficiency in CKD: A Cross-Sectional Study Across Latitudes in the United StatesAmerican Journal of Kidney Diseases, 2005
- Altered Pharmacokinetics of 1α,25-Dihydroxyvitamin D3and 25-Hydroxyvitamin D3in the Blood and Tissues of the 25-Hydroxyvitamin D-24-Hydroxylase (Cyp24a1) Null MouseEndocrinology, 2005
- Vitamin D Insufficiency and Deficiency in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2004
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisThe New England Journal of Medicine, 2004
- A Comparison of Prediction Equations for Estimating Glomerular Filtration Rate in Adults without Kidney DiseaseJournal of the American Society of Nephrology, 2003
- Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination surveyAmerican Journal of Kidney Diseases, 2003
- Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failureNephrology Dialysis Transplantation, 2002
- Importance of vitamin D repletion in uraemia.Nephrology Dialysis Transplantation, 1999
- Hypovitaminosis D in Medical InpatientsThe New England Journal of Medicine, 1998
- Plasma Vitamin D Metabolite Concentrations in Chronic Renal Failure: Effect of Oral Administration of 25-Hydroxyvitamin D3*Journal of Clinical Endocrinology & Metabolism, 1984